Top

Acta Neurochirurgica

Published in:

01-12-2014 | Experimental research - Brain Tumors

Immunohistochemical profile of the dural tail in intracranial meningiomas

Authors: Min Wen, Shin Jung, Kyung-Sub Moon, Jian Pei, Kyung-Hwa Lee, Shu-Guang Jin, Song-Yuan Li, Hyang-Hwa Ryu

Published in: Acta Neurochirurgica | Issue 12/2014

Abstract

Objective

The dural tail sign was first described as a thin, tapering rim of dural enhancement, in continuity with meningiomas on enhanced T1-weighted magnetic resonance (MR) images. However, the exact nature of the dural tail is still unclear. This study investigated the immunohistochemical (IHC) characteristics of the dural tail in intracranial meningiomas and the correlation between clinicopathological profiles and tumor invasion of the dural tail.

Methods

The study group consisted of 36 patients of meningioma with the dural tail noted on MR imaging and in pathological findings, and 18 patients of meningioma without the dural tail as the control group. IHC staining of tumor masses and dural tails for vascular endothelial growth factor (VEGF), epithelial membrane antigen, CD34, Ki-67, and vimentin were performed.

Results

The data showed that 61.1 % (22/36) of cases in the study group revealed tumor invasion of dural tail, and 55.6 % (30/54) of all the cases demonstrated dura mater invasion in all the samples. The dura mater invasion was significantly positively related to invasion of the dural tail in the study group (p = 0.009). IHC staining detected higher expression of VEGF and CD34 in the dural tail than in the main tumor mass.

Conclusions

Considering the high proportion of patients with tumor invasion into the dural tail, we tried to perform wide resection of the dural tail during intracranial meningioma surgery. Furthermore, VEGF was strongly expressed in tumor cells that invaded into the dural tail, and hence VEGF can be used as a marker to differentiate tumor cells from normal meningeal cells in the dural tail.

Abdelzaher E, Mohamed Abdallah D (2014) Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int 2014:7CrossRef

Arana E, Marti-Bonmati L, Ricart V, Pérez-Ebrí M (2004) Dural enhancement with primary calvarial lesions. Neuroradiology 46:900–905PubMedCrossRef

Barresi V, Cerasoli S, Vitarelli E, Tuccari G (2007) Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147–156PubMedCrossRef

Barresi V, Vitarelli E, Cerasoli S (2009) Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch 454:563–571PubMedCrossRef

Borovich B, Doron Y (1986) Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 64:58–63PubMedCrossRef

Borovich B, Doron Y, Braun J, Feinsod M, Goldsher D, Gruszkiewicz J, Guilburd J, Zaaroor M, Levi L, Soustiel J (1988) The incidence of multiple meningiomas—Do solitary meningiomas exist? Acta Neurochir (Wien) 90:15–22CrossRef

Christov C, Lechapt-Zalcman E, Adle-Biassette H, Nachev S, Gherardi RK (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420PubMedCrossRef

Cordell J, Richardson T, Pulford K, Ghosh A, Gatter K, Heyderman E, Mason D (1985) Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 52:347PubMedCentralPubMedCrossRef

Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25PubMedCrossRef

10.

Goldsher D, Litt A, Pinto R, Bannon K, Kricheff I (1990) Dural "tail" associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, and possible implications for treatment. Radiology 176:447–450PubMedCrossRef

11.

Guermazi A, Lafitte F, Miaux Y, Adem C, Bonneville JF, Chiras J (2005) The dural tail sign–beyond meningioma. Clin Radiol 60:171–188PubMedCrossRef

12.

Heyderman E, Steele K, Ormerod M (1979) A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue. J Clin Pathol 32:35–39PubMedCentralPubMedCrossRef

13.

Hiyama H, Kubo O, Tajika Y, Tohyama T, Takakura K (1994) Meningiomas associated with peritumoural venous stasis: three types on cerebral angiogram. Acta Neurochir (Wien) 129:31–38CrossRef

14.

Hutzelmann A, Palmie S, Buhl R, Freund M, Heller M (1998) Dural invasion of meningiomas adjacent to the tumor margin on Gd-DTPA-enhanced MR images: histopathologic correlation. Eur Radiol 8:746–748PubMedCrossRef

15.

Jensen R, Lee J (2012) Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery 71:146–156PubMedCrossRef

16.

Kalkanis SN, Carroll RS, Zhang J, Zamani AA, Black PM (1996) Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 85:1095–1101PubMedCrossRef

17.

Kawahara Y, Niiro M, Yokoyama S, Kuratsu J (2001) Dural congestion accompanying meningioma invasion into vessels: the dural tail sign. Neuroradiology 43:462–465PubMedCrossRef

18.

Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309–1312PubMedCrossRef

19.

Larson J, Tew J Jr, Wiot J, de Courten-Myers G (1992) Association of meningiomas with dural “tails”; surgical significance. Acta Neurochir (Wien) 114:59–63CrossRef

20.

Ng H, Tse CC, Lo ST (1987) Meningiomas and arachnoid cells: an immunohistochemical study of epithelial markers. Pathology 19:253–257PubMedCrossRef

21.

Nielsen JS, McNagny KM (2008) Novel functions of the CD34 family. J Cell Sci 121:3683–3692PubMedCrossRef

22.

Otsuka S, Tamiya T, Ono Y, Michiue H, Kurozumi K, Daido S, Kambara H, Date I, Ohmoto T (2004) The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol 70:349–357PubMedCrossRef

23.

Pinkus GS, Kurtin PJ (1985) Epithelial membrane antigen—a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol 16:929–940PubMedCrossRef

24.

Pistolesi S, Fontanini G, Camacci T, De Ieso K, Boldrini L, Lupi G, Padolecchia R, Pingitore R, Parenti G (2002) Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply. J Neurooncol 60:159–164PubMedCrossRef

25.

Preusser M, Hassler M, Birner P, Rudas M, Acker T, Plate KH, Widhalm G, Knosp E, Breitschopf H, Berger J (2012) Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches. Clin Neuropathol 31:351–360

26.

Provias J, Claffey K, Lau N, Feldkamp M, Guha A (1997) Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016–1026PubMedCrossRef

27.

S-t Q, Liu Y, Pan J, Chotai S, Fang L-x (2012) A radiopathological classification of dural tail sign of meningiomas: laboratory investigation. J Neurosurg 117:645–653CrossRef

28.

Rokni-Yazdi H, Azmoudeh Ardalan F, Asadzandi Z, Sotoudeh H, Shakiba M, Adibi A, Ayatollahi H, Rahmani M (2009) Pathologic significance of the “dural tail sign”. Eur J Radiol 70:10–16PubMedCrossRef

29.

Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189–1193PubMed

30.

Schörner W, Schubeus P, Henkes H, Lanksch W, Felix R (1990) ““Meningeal sign”: a characteristic finding of meningiomas on contrast-enhanced MR images. Neuroradiology 32:90–93PubMedCrossRef

31.

Schmid S, Aboul-Enein F, Pfisterer W, Birkner T, Stadek C, Knosp E (2010) Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients. Neurosurgery 67:1703–1708PubMedCrossRef

32.

Schnitt SJ, Vogel H (1986) Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol 10:640–649PubMedCrossRef

33.

Sekiya T, Manabe H, Iwabuchi T, Narita T (1992) The dura mater adjacent to the attachment of meningiomas: its enhanced MR imaging and histological findings. No Shinkei Geka 20:1063PubMed

34.

Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983–985PubMedCrossRef

35.

Strugar J, Rothbart D, Harrington W, Criscuolo GR (1994) Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81:560–566PubMedCrossRef

36.

Tokumaru A, O'uchi T, Eguchi T, Kawamoto S, Kokubo T, Suzuki M, Kameda T (1990) Prominent meningeal enhancement adjacent to meningioma on Gd-DTPA-enhanced MR images: histopathologic correlation. Radiology 175:431–433PubMedCrossRef

37.

Wilms G, Lammens M, Marchal G, Van Calenbergh F, Plets C, Van Fraeyenhoven L, Baert AL (1989) Thickening of dura surrounding meningiomas: MR features. J Comput Assist Tomogr 13:763–768PubMedCrossRef

38.

Winek RR, Scheithauer BW, Wick MR (1989) Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma: a comparative immunohistochemical study. Am J Surg Pathol 13:251–261PubMedCrossRef

39.

Yamasaki F, Yoshioka H, Hama S, Sugiyama K, Arita K, Kurisu K (2000) Recurrence of meningiomas. Cancer 89:1102–1110PubMedCrossRef

Title: Immunohistochemical profile of the dural tail in intracranial meningiomas
Authors: Min Wen
Shin Jung
Kyung-Sub Moon
Jian Pei
Kyung-Hwa Lee
Shu-Guang Jin
Song-Yuan Li
Hyang-Hwa Ryu
Publication date: 01-12-2014
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 12/2014
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-014-2216-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Immunohistochemical profile of the dural tail in intracranial meningiomas

Abstract

Objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2014

Schwannomas of the upper extremity: analysis of 34 cases

Shock wave trauma leads to inflammatory response and morphological activation in macrophage cell lines, but does not induce iNOS or NO synthesis

Subdural motor cortex stimulation: feasibility, efficacy and security on a series of 18 consecutive cases with a follow-up of at least 3 years

An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly

Predictive value of diffusion-weighted MRI for tumor consistency and resection rate of nonfunctional pituitary macroadenomas

The minimally invasive endoscopic management of septated chronic subdural hematomas: surgical technique